Form 4: AbbVie Director Robert Alpern Reports Acquisition and Disposal of Common Stock

Director Robert Alpern reports acquiring and disposing of AbbVie common stock and restricted stock units.

Summary

• On May 9, 2025, Robert J. Alpern, a director of AbbVie Inc., reported a transaction involving AbbVie's common stock.
• Alpern acquired 1,203 shares of common stock.
• Alpern also disposed of 35,646 shares of common stock.
• Additionally, Alpern was awarded restricted stock units under the AbbVie Amended and Restated 2013 Incentive Stock Program.
• These restricted stock units will be paid in shares of AbbVie common stock on a one-to-one basis upon separation from service, death, or a change in control.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock transactions by a company director. It doesn't inherently convey positive or negative sentiment.

Future Outlook

The restricted stock units will be paid out in AbbVie common stock upon the director's separation from service, death, or a change in control, as defined in the AbbVie Amended and Restated 2013 Incentive Stock Program.

Industry Context

Form 4 filings are standard disclosures required by the SEC for corporate insiders, providing transparency into their transactions in the company's stock. This allows investors to monitor the actions of those with privileged information.

Stakeholder Impact

• The transactions reported may be of interest to shareholders as they provide insight into the actions of a company director.

Key Dates

Keywords

AbbVie, Robert Alpern, Director, Form 4, Stock, Restricted Stock Units, ABBV, Acquisition, Disposal